Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma
Trial details
- Registry ID
- NCT02678572
- Phase
- Phase 3
Drug identity has not yet been verified against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular MelanomaNCT02678572 | DCTH | Phase 3 | Completed | 2023-05-18Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |